Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 85,695 | 80,800 | 81,567 | 73,890 | 69,443 |
| Gross Profit | 85,695 | 80,800 | 81,567 | 73,890 | 69,443 |
| Operating Expenses | 34,856 | 32,037 | 34,876 | 36,171 | 36,950 |
| Operating Income | 50,839 | 48,763 | 46,691 | 37,719 | 32,493 |
| Interest Expense | 11,114 | 11,172 | 12,169 | 15,420 | 15,702 |
| Other Income | 74 | -410 | -1,803 | -3,100 | -335 |
| Pre-tax Income | 39,799 | 37,181 | 32,719 | 19,199 | 16,456 |
| Income Tax | 1,856 | 2,504 | -2,000 | 1,697 | 904 |
| Net Income Continuous | 37,943 | 34,677 | 34,719 | 17,502 | 15,552 |
| Net Income Discontinuous | N/A | 1,063 | -20,473 | -2,059 | -16,178 |
| Net Income | $37,943 | $35,740 | $14,246 | $15,443 | $-626 |
| EPS Basic Total Ops | 2.07 | 1.94 | 0.69 | 0.75 | -0.16 |
| EPS Basic Continuous Ops | 2.07 | 1.88 | 1.85 | 0.87 | 0.76 |
| EPS Basic Discontinuous Ops | N/A | 0.06 | -1.16 | -0.12 | -0.92 |
| EPS Diluted Total Ops | 2.04 | 1.91 | 0.67 | 0.75 | -0.16 |
| EPS Diluted Continuous Ops | 2.04 | 1.85 | 1.82 | 0.86 | 0.76 |
| EPS Diluted Discontinuous Ops | N/A | 0.06 | -1.15 | -0.11 | -0.92 |
| EPS Diluted Before Non-Recurring Items | 2.04 | 1.85 | 1.76 | 1.04 | 0.78 |
| EBITDA(a) | $81,117 | $78,344 | $77,787 | $70,388 | $60,666 |